Id |
Subject |
Object |
Predicate |
Lexical cue |
T5332 |
44-56 |
Protein |
denotes |
CCR5−/− Mice |
T5329 |
68-75 |
Protein |
denotes |
of CCR5 |
T5343 |
140-144 |
Protein |
denotes |
mice |
T5344 |
146-167 |
Entity |
denotes |
B16-F0 melanoma cells |
T5347 |
224-228 |
Protein |
denotes |
mice |
T5348 |
230-234 |
Entity |
denotes |
n = |
T5330 |
295-311 |
Protein |
denotes |
the CCR5−/− mice |
T5340 |
349-365 |
Protein |
denotes |
the CCR5+/+ mice |
T5342 |
387-403 |
Protein |
denotes |
the CCR5−/− mice |
T5327 |
454-462 |
Protein |
denotes |
the CCR5 |
T5326 |
466-470 |
Protein |
denotes |
mice |
T5341 |
619-623 |
Protein |
denotes |
mice |
T5349 |
709-736 |
Protein |
denotes |
mice (75% of starting time) |
T5324 |
741-759 |
Protein |
denotes |
CCR5+/+ mice (15%) |
T5339 |
863-875 |
Protein |
denotes |
CCR5−/− mice |
T5325 |
880-892 |
Protein |
denotes |
CCR5+/+ mice |
T5338 |
935-956 |
Protein |
denotes |
CCR5−/− mice survived |
T5336 |
963-1000 |
Protein |
denotes |
only 15% of the CCR5+/+ mice survived |
T5345 |
972-1000 |
Protein |
denotes |
of the CCR5+/+ mice survived |
T5335 |
1042-1061 |
Protein |
denotes |
the sacrificed mice |
T5333 |
1166-1193 |
Entity |
denotes |
proliferation antigen PCNA, |
T5323 |
1166-1193 |
Protein |
denotes |
proliferation antigen PCNA, |
T5331 |
1254-1258 |
Protein |
denotes |
mice |
T5328 |
1336-1385 |
Protein |
denotes |
of the CCR5−/− mice, but not those of the CCR5+/+ |
T5350 |
1386-1391 |
Protein |
denotes |
mice, |
T5337 |
1427-1431 |
Protein |
denotes |
PCNA |
T5334 |
1427-1446 |
Entity |
denotes |
PCNA reactive cells |
T5346 |
1489-1505 |
Protein |
denotes |
mice (Figure 1E) |
T17675 |
1586-1598 |
Protein |
denotes |
CCR5−/− mice |
T17677 |
1600-1603 |
Protein |
denotes |
A–C |
T17672 |
1641-1679 |
Entity |
denotes |
B16 melanoma cells (5×105 cells/mouse) |
T17683 |
1706-1735 |
Protein |
denotes |
CCR5+/+ mice and CCR5−/− mice |
T17685 |
1714-1718 |
Protein |
denotes |
mice |
T17676 |
1737-1741 |
Entity |
denotes |
n = |
T17684 |
1847-1863 |
Protein |
denotes |
The CCR5−/− mice |
T17678 |
1931-1946 |
Protein |
denotes |
to CCR5+/+ mice |
T17680 |
1977-1986 |
Protein |
denotes |
mean ± SD |
T17679 |
2028-2049 |
Protein |
denotes |
CCR5+/+ mice (P<0.05) |
T17686 |
2066-2070 |
Protein |
denotes |
mice |
T17682 |
2129-2163 |
Protein |
denotes |
to CCR5+/+ mice (by Log-rank Test) |
T17687 |
2214-2269 |
Gene_expression |
denotes |
expression of proliferating cell nuclear antigen (PCNA) |
T17673 |
2225-2269 |
Protein |
denotes |
of proliferating cell nuclear antigen (PCNA) |
T17681 |
2264-2268 |
Protein |
denotes |
PCNA |
T17671 |
2312-2345 |
Entity |
denotes |
S.D. of four experimental animals |
T17674 |
2387-2408 |
Protein |
denotes |
CCR5+/+ mice (P<0.05) |
T18161 |
2437-2490 |
Negative_regulation |
denotes |
Decrease of NF-κB Activity in Tumor Tissue of CCR5−/− |
T5902 |
2437-2490 |
Negative_regulation |
denotes |
Decrease of NF-κB Activity in Tumor Tissue of CCR5−/− |
T18152 |
2449-2454 |
Protein |
denotes |
NF-κB |
T5893 |
2449-2454 |
Protein |
denotes |
NF-κB |
T18147 |
2491-2495 |
Protein |
denotes |
Mice |
T5884 |
2491-2495 |
Protein |
denotes |
Mice |
T5899 |
2496-2519 |
Positive_regulation |
denotes |
The activation of NF-κB |
T5892 |
2511-2519 |
Protein |
denotes |
of NF-κB |
T5896 |
2545-2566 |
Entity |
denotes |
cancer cell survival, |
T5885 |
2578-2599 |
Entity |
denotes |
melanoma cancer cells |
T5887 |
2607-2611 |
Protein |
denotes |
CCR5 |
T5900 |
2607-2622 |
Gene_expression |
denotes |
CCR5 expression |
T5903 |
2682-2719 |
Negative_regulation |
denotes |
the inactivation of NF-κB in melanoma |
T5897 |
2699-2707 |
Protein |
denotes |
of NF-κB |
T5890 |
2746-2754 |
Protein |
denotes |
of NF-κB |
T5886 |
2905-2909 |
Protein |
denotes |
mice |
T5901 |
2946-3086 |
Negative_regulation |
denotes |
the translocation of p50 and p-p65 into the nucleus through the inhibition of phosphorylation of IκB was also prevented in the tumor tissues |
T5898 |
2967-2970 |
Protein |
denotes |
p50 |
T5889 |
2975-2980 |
Protein |
denotes |
p-p65 |
T5891 |
2986-2997 |
Entity |
denotes |
the nucleus |
T5894 |
3098-3114 |
Protein |
denotes |
mice (Figure 2B) |
T5895 |
3202-3205 |
Protein |
denotes |
p50 |
T5888 |
3252-3268 |
Protein |
denotes |
mice (Figure 2C) |
T18159 |
3441-3464 |
Entity |
denotes |
extracts of the CCR5−/− |
T18151 |
3465-3469 |
Protein |
denotes |
mice |
T18153 |
3474-3486 |
Protein |
denotes |
CCR5+/+ mice |
T18162 |
3547-3564 |
Gene_expression |
denotes |
Expression of p50 |
T18158 |
3558-3564 |
Protein |
denotes |
of p50 |
T18149 |
3569-3572 |
Protein |
denotes |
p65 |
T18163 |
3569-3614 |
Phosphorylation |
denotes |
p65 phosphorylation in nuclear extracts (NE), |
T18148 |
3592-3613 |
Entity |
denotes |
nuclear extracts (NE) |
T18155 |
3650-3661 |
Entity |
denotes |
the cytosol |
T18160 |
3731-3737 |
Protein |
denotes |
of p50 |
T18157 |
3793-3796 |
Protein |
denotes |
p50 |
T18156 |
3844-3848 |
Protein |
denotes |
mice |
T18150 |
3867-3900 |
Entity |
denotes |
S.D. of four experimental animals |
T18154 |
3942-3963 |
Protein |
denotes |
CCR5+/+ mice (p<0.05) |
T6415 |
4031-4095 |
Negative_regulation |
denotes |
Inhibition of the Expression of Anti-apoptotic Proteins in CCR5− |
T6408 |
4068-4095 |
Protein |
denotes |
apoptotic Proteins in CCR5− |
T6399 |
4098-4102 |
Protein |
denotes |
Mice |
T6413 |
4118-4146 |
Negative_regulation |
denotes |
inhibition of NF-κB activity |
T6396 |
4132-4137 |
Protein |
denotes |
NF-κB |
T6414 |
4307-4361 |
Gene_expression |
denotes |
expression of apoptotic cell death regulatory proteins |
T6398 |
4318-4361 |
Protein |
denotes |
of apoptotic cell death regulatory proteins |
T6404 |
4454-4466 |
Protein |
denotes |
CCR5−/− mice |
T6403 |
4493-4507 |
Entity |
denotes |
melanoma cells |
T6410 |
4579-4616 |
Protein |
denotes |
the tumor tissues of the CCR5−/− mice |
T6412 |
4579-4617 |
Localization |
denotes |
the tumor tissues of the CCR5−/− mice |
T6395 |
4630-4658 |
Protein |
denotes |
the CCR5+/+ mice (Figure 3A) |
T6397 |
4738-4747 |
Protein |
denotes |
caspase-3 |
T6405 |
4752-4755 |
Protein |
denotes |
Bax |
T6411 |
4798-4802 |
Protein |
denotes |
mice |
T6401 |
4811-4846 |
Protein |
denotes |
the CCR5+/+ mice (Figure 3B and 3C) |
T6406 |
4916-4933 |
Protein |
denotes |
of tumor proteins |
T6394 |
4959-5006 |
Protein |
denotes |
levels of cleaved caspase-3, cleaved caspase-9, |
T6400 |
4996-5005 |
Protein |
denotes |
caspase-9 |
T6409 |
5015-5019 |
Protein |
denotes |
PARP |
T6407 |
5024-5027 |
Protein |
denotes |
Bax |
T6392 |
5051-5056 |
Protein |
denotes |
Bcl-2 |
T6402 |
5061-5067 |
Protein |
denotes |
C-IAP1 |
T6393 |
5108-5112 |
Protein |
denotes |
mice |
T18555 |
5215-5245 |
Localization |
denotes |
tumor tissues of CCR5 −/− mice |
T18545 |
5215-5245 |
Protein |
denotes |
tumor tissues of CCR5 −/− mice |
T18546 |
5229-5236 |
Protein |
denotes |
of CCR5 |
T18538 |
5260-5265 |
Entity |
denotes |
cells |
T18527 |
5331-5335 |
Entity |
denotes |
DAPI |
T18537 |
5442-5457 |
Entity |
denotes |
of DAPI-stained |
T18544 |
5459-5489 |
Entity |
denotes |
TUNEL-positive cells that were |
T18540 |
5521-5554 |
Protein |
denotes |
S.D. of four experimental animals |
T18539 |
5611-5623 |
Protein |
denotes |
CCR5+/+ mice |
T18535 |
5661-5706 |
Protein |
denotes |
Apoptotic protein (cleaved caspase-3 and Bax) |
T18525 |
5688-5697 |
Protein |
denotes |
caspase-3 |
T18543 |
5702-5705 |
Protein |
denotes |
Bax |
T18532 |
5822-5899 |
Entity |
denotes |
of DAPI-stained, Specific antibody (cleaved caspase-3 and Bax)-positive cells |
T18536 |
5825-5837 |
Entity |
denotes |
DAPI-stained |
T18553 |
5848-5884 |
Entity |
denotes |
antibody (cleaved caspase-3 and Bax) |
T18552 |
5866-5875 |
Protein |
denotes |
caspase-3 |
T18533 |
5880-5883 |
Protein |
denotes |
Bax |
T18547 |
5941-5974 |
Protein |
denotes |
S.D. of four experimental animals |
T18551 |
6031-6043 |
Protein |
denotes |
CCR5+/+ mice |
T18554 |
6075-6111 |
Gene_expression |
denotes |
The expression of apoptotic proteins |
T18530 |
6090-6111 |
Protein |
denotes |
of apoptotic proteins |
T18549 |
6151-6170 |
Entity |
denotes |
specific antibodies |
T18534 |
6180-6209 |
Protein |
denotes |
caspase-3, cleaved caspase-9, |
T18542 |
6199-6208 |
Protein |
denotes |
caspase-9 |
T18529 |
6218-6222 |
Protein |
denotes |
PARP |
T18526 |
6224-6227 |
Protein |
denotes |
Bax |
T18541 |
6229-6234 |
Protein |
denotes |
Bcl-2 |
T18548 |
6239-6245 |
Protein |
denotes |
c-IAP1 |
T18524 |
6268-6287 |
Protein |
denotes |
The β-actin protein |
T18550 |
6268-6287 |
Protein |
denotes |
The β-actin protein |
T18528 |
6409-6443 |
Entity |
denotes |
S.D. of three experimental animals |
T18531 |
6485-6506 |
Protein |
denotes |
CCR5+/+ mice (p<0.05) |
T19295 |
6509-6564 |
Positive_regulation |
denotes |
Upregulation of IL-1Ra in the Tumor and Spleen of CCR5− |
T7227 |
6509-6571 |
Positive_regulation |
denotes |
Upregulation of IL-1Ra in the Tumor and Spleen of CCR5−/− Mice |
T19293 |
6522-6531 |
Protein |
denotes |
of IL-1Ra |
T7223 |
6522-6531 |
Protein |
denotes |
of IL-1Ra |
T19286 |
6535-6564 |
Protein |
denotes |
the Tumor and Spleen of CCR5− |
T7212 |
6559-6571 |
Protein |
denotes |
CCR5−/− Mice |
T19288 |
6567-6571 |
Protein |
denotes |
Mice |
T7219 |
6605-6617 |
Protein |
denotes |
the cytokine |
T7214 |
6689-6693 |
Protein |
denotes |
mice |
T7218 |
6708-6771 |
Protein |
denotes |
a cytokine array assay using a Mouse Proteome Array (Figure 4A) |
T7208 |
6789-6821 |
Protein |
denotes |
cytokines, the levels of IL-1Ra, |
T7217 |
6814-6820 |
Protein |
denotes |
IL-1Ra |
T7220 |
6822-6826 |
Protein |
denotes |
MIG, |
T7207 |
6822-6833 |
Protein |
denotes |
MIG, MIP-1α |
T7224 |
6894-6898 |
Protein |
denotes |
mice |
T7206 |
6919-6923 |
Protein |
denotes |
mice |
T7211 |
6947-6965 |
Protein |
denotes |
no other cytokines |
T7213 |
7001-7017 |
Protein |
denotes |
the CCR5−/− mice |
T7210 |
7022-7050 |
Protein |
denotes |
the CCR5+/+ mice (Figure 4B) |
T7221 |
7110-7137 |
Protein |
denotes |
of CCR5−/− mice (Figure 4C) |
T7209 |
7149-7155 |
Protein |
denotes |
IL-1Ra |
T7226 |
7199-7298 |
Gene_expression |
denotes |
the expression of IL-1Ra in tumor and spleen tissues was analyzed by immunofluorescence and western |
T7216 |
7214-7223 |
Protein |
denotes |
of IL-1Ra |
T7228 |
7309-7333 |
Gene_expression |
denotes |
The expression of IL-1Ra |
T7225 |
7309-7392 |
Positive_regulation |
denotes |
The expression of IL-1Ra was upregulated in tumor and spleen tissues of the CCR5−/− |
T7215 |
7324-7333 |
Protein |
denotes |
of IL-1Ra |
T7222 |
7393-7397 |
Protein |
denotes |
mice |
T19268 |
7544-7582 |
Protein |
denotes |
mouse cytokine array panel coordinates |
T19292 |
7584-7598 |
Entity |
denotes |
Nitrocellulose |
T19281 |
7584-7608 |
Entity |
denotes |
Nitrocellulose membranes |
T19275 |
7620-7654 |
Entity |
denotes |
different anti-cytokine antibodies |
T19278 |
7686-7706 |
Protein |
denotes |
cytokine array panel |
T19297 |
7716-7795 |
Gene_expression |
denotes |
the cytokine expression difference in tumor tissues of CCR5+/+ mice and CCR5−/− |
T19267 |
7720-7728 |
Protein |
denotes |
cytokine |
T19283 |
7771-7783 |
Protein |
denotes |
CCR5+/+ mice |
T19269 |
7796-7801 |
Protein |
denotes |
mice, |
T19279 |
7796-7819 |
Entity |
denotes |
mice, especially IL-1Ra |
T19271 |
7965-7977 |
Entity |
denotes |
the membrane |
T19276 |
7979-8003 |
Protein |
denotes |
C, Protein immune-arrays |
T19294 |
8025-8063 |
Protein |
denotes |
Mouse cytokine array in spleen tissues |
T19291 |
8091-8100 |
Protein |
denotes |
cytokines |
T19289 |
8109-8139 |
Protein |
denotes |
CCR5+/+ mice and CCR5−/− mice, |
T19282 |
8117-8121 |
Protein |
denotes |
mice |
T19270 |
8303-8315 |
Entity |
denotes |
the membrane |
T19290 |
8402-8408 |
Protein |
denotes |
IL-1Ra |
T19277 |
8492-8539 |
Protein |
denotes |
of DAPI-stained, IL-1Ra antibody-positive cells |
T19274 |
8495-8507 |
Entity |
denotes |
DAPI-stained |
T19280 |
8516-8524 |
Protein |
denotes |
antibody |
T19273 |
8581-8614 |
Entity |
denotes |
S.D. of four experimental animals |
T19287 |
8671-8683 |
Protein |
denotes |
CCR5+/+ mice |
T19296 |
8721-8802 |
Gene_expression |
denotes |
Expression of IL-1Ra was analyzed by western blotting in tumor and spleen tissues |
T19272 |
8732-8741 |
Protein |
denotes |
of IL-1Ra |
T19284 |
8892-8926 |
Entity |
denotes |
S.D. of three experimental animals |
T19285 |
8968-8989 |
Protein |
denotes |
CCR5+/+ mice (p<0.05) |
T8653 |
9005-9008 |
Protein |
denotes |
CD8 |
T8612 |
9005-9016 |
Entity |
denotes |
CD8 T cells |
T8633 |
9021-9028 |
Entity |
denotes |
NK Cell |
T8636 |
9047-9079 |
Protein |
denotes |
Tumor and Spleen of CCR5−/− Mice |
T8637 |
9137-9149 |
Protein |
denotes |
CCR5−/− mice |
T8668 |
9238-9259 |
Entity |
denotes |
CD8+ cytotoxic T cell |
T8634 |
9264-9318 |
Entity |
denotes |
CD57+ Natural Killer cells in tumor and spleen tissues |
T8667 |
9356-9368 |
Protein |
denotes |
CCR5−/− mice |
T8666 |
9418-9428 |
Entity |
denotes |
CD8+ cells |
T8669 |
9445-9518 |
Binding |
denotes |
as well as an increase in the number of infiltrating NK cells (Figure 5A) |
T8627 |
9498-9518 |
Entity |
denotes |
NK cells (Figure 5A) |
T8635 |
9520-9532 |
Entity |
denotes |
CD8+ T cells |
T8671 |
9520-9604 |
Binding |
denotes |
CD8+ T cells and CD57+ NK cells were spread diffusely throughout the entire sections |
T8658 |
9537-9551 |
Entity |
denotes |
CD57+ NK cells |
T8646 |
9660-9675 |
Entity |
denotes |
of CD8+ T cells |
T8652 |
9680-9694 |
Entity |
denotes |
CD57+ NK cells |
T8659 |
9703-9715 |
Protein |
denotes |
CCR5+/+ mice |
T8643 |
9720-9725 |
Protein |
denotes |
CCR5− |
T8670 |
9726-9759 |
Localization |
denotes |
− mice in immunity-related organ, |
T8618 |
9726-9759 |
Protein |
denotes |
− mice in immunity-related organ, |
T8611 |
9777-9784 |
Protein |
denotes |
the CD8 |
T8632 |
9789-9793 |
Protein |
denotes |
CD57 |
T8625 |
9845-9860 |
Entity |
denotes |
of CD8+ T cells |
T8623 |
9865-9879 |
Entity |
denotes |
CD57+ NK cells |
T8631 |
9921-9925 |
Protein |
denotes |
mice |
T8638 |
9945-9964 |
Protein |
denotes |
of the CCR5+/+ mice |
T8639 |
10035-10038 |
Protein |
denotes |
CD8 |
T8622 |
10035-10046 |
Entity |
denotes |
CD8 T cells |
T8624 |
10051-10059 |
Entity |
denotes |
NK cells |
T8641 |
10078-10087 |
Entity |
denotes |
cytotoxic |
T8651 |
10155-10167 |
Protein |
denotes |
CCR5−/− mice |
T19901 |
10246-10258 |
Entity |
denotes |
CD8+ T cells |
T19905 |
10263-10271 |
Entity |
denotes |
NK cells |
T19902 |
10318-10322 |
Protein |
denotes |
mice |
T19903 |
10409-10451 |
Protein |
denotes |
CD8 (CD8+ cytotoxic T-cell surface marker) |
T19897 |
10414-10450 |
Entity |
denotes |
CD8+ cytotoxic T-cell surface marker |
T19896 |
10414-10450 |
Entity |
denotes |
CD8+ cytotoxic T-cell surface marker |
T19894 |
10414-10450 |
Entity |
denotes |
CD8+ cytotoxic T-cell surface marker |
T19900 |
10462-10469 |
Entity |
denotes |
NK cell |
T19904 |
10663-10687 |
Entity |
denotes |
of lymphocyte phenotypes |
T19895 |
10808-10832 |
Protein |
denotes |
FACSAria flow cytometry, |
T19899 |
10812-10816 |
Protein |
denotes |
Aria |
T19898 |
10881-10914 |
Entity |
denotes |
S.D. of four experimental animals |
T8616 |
10927-10963 |
Entity |
denotes |
the cell phenotype change in CCR5−/− |
T8649 |
10964-10968 |
Protein |
denotes |
mice |
T8642 |
10973-11022 |
Protein |
denotes |
CCR5+/+ mice by inoculation of the melanoma cell, |
T8629 |
11001-11021 |
Entity |
denotes |
of the melanoma cell |
T8621 |
11023-11034 |
Entity |
denotes |
lymphocytes |
T8644 |
11091-11094 |
Protein |
denotes |
CD3 |
T8610 |
11091-11096 |
Entity |
denotes |
CD3 T |
T8606 |
11098-11101 |
Protein |
denotes |
CD4 |
T8626 |
11098-11103 |
Entity |
denotes |
CD4 T |
T8608 |
11108-11111 |
Entity |
denotes |
8 T |
T8665 |
11116-11123 |
Entity |
denotes |
NK cell |
T8647 |
11143-11147 |
Protein |
denotes |
mice |
T8630 |
11256-11268 |
Protein |
denotes |
3.1% of CCR5 |
T8640 |
11272-11288 |
Protein |
denotes |
mice (Figure 5C) |
T8619 |
11290-11354 |
Entity |
denotes |
The lymphocytes that infiltrated the tumor tissue of the CCR5−/− |
T8656 |
11355-11359 |
Protein |
denotes |
mice |
T8655 |
11386-11401 |
Protein |
denotes |
CD19, CD3, CD4, |
T8660 |
11386-11405 |
Protein |
denotes |
CD19, CD3, CD4, CD8 |
T8663 |
11392-11396 |
Protein |
denotes |
CD3, |
T8620 |
11392-11400 |
Protein |
denotes |
CD3, CD4 |
T8654 |
11429-11448 |
Protein |
denotes |
to the CCR5+/+ mice |
T8657 |
11457-11460 |
Protein |
denotes |
CD3 |
T8628 |
11457-11462 |
Entity |
denotes |
CD3 T |
T8661 |
11464-11467 |
Protein |
denotes |
CD4 |
T8648 |
11464-11469 |
Entity |
denotes |
CD4 T |
T8617 |
11476-11477 |
Entity |
denotes |
T |
T8615 |
11482-11512 |
Entity |
denotes |
NK cell portion of the CCR5−/− |
T8609 |
11513-11517 |
Protein |
denotes |
mice |
T8664 |
11619-11655 |
Protein |
denotes |
3.9% of the CCR5+/+ mice (Figure 5D) |
T8607 |
11624-11655 |
Protein |
denotes |
of the CCR5+/+ mice (Figure 5D) |
T8614 |
11714-11717 |
Protein |
denotes |
CD8 |
T8650 |
11714-11725 |
Entity |
denotes |
CD8 T cells |
T8645 |
11730-11738 |
Entity |
denotes |
NK cells |
T8613 |
11757-11766 |
Entity |
denotes |
cytotoxic |
T8662 |
11844-11856 |
Protein |
denotes |
CCR5−/− mice |
R12778 |
T17673 |
T17687 |
themeOf |
of proliferating cell nuclear antigen (PCNA),expression of proliferating cell nuclear antigen (PCNA) |
R13081 |
T18149 |
T18163 |
themeOf |
p65,"p65 phosphorylation in nuclear extracts (NE)," |
R13082 |
T18152 |
T18161 |
themeOf |
NF-κB,Decrease of NF-κB Activity in Tumor Tissue of CCR5−/− |
R13083 |
T18158 |
T18162 |
themeOf |
of p50,Expression of p50 |
R13302 |
T18530 |
T18554 |
themeOf |
of apoptotic proteins,The expression of apoptotic proteins |
R13303 |
T18545 |
T18555 |
themeOf |
tumor tissues of CCR5 −/− mice,tumor tissues of CCR5 −/− mice |
R13800 |
T19267 |
T19297 |
themeOf |
cytokine,the cytokine expression difference in tumor tissues of CCR5+/+ mice and CCR5−/− |
R13801 |
T19272 |
T19296 |
themeOf |
of IL-1Ra,Expression of IL-1Ra was analyzed by western blotting in tumor and spleen tissues |
R13802 |
T19293 |
T19295 |
themeOf |
of IL-1Ra,Upregulation of IL-1Ra in the Tumor and Spleen of CCR5− |
R4050 |
T5887 |
T5900 |
themeOf |
CCR5,CCR5 expression |
R4051 |
T5892 |
T5899 |
themeOf |
of NF-κB,The activation of NF-κB |
R4052 |
T5893 |
T5902 |
themeOf |
NF-κB,Decrease of NF-κB Activity in Tumor Tissue of CCR5−/− |
R4053 |
T5897 |
T5903 |
themeOf |
of NF-κB,the inactivation of NF-κB in melanoma |
R4353 |
T6398 |
T6414 |
themeOf |
of apoptotic cell death regulatory proteins,expression of apoptotic cell death regulatory proteins |
R4354 |
T6410 |
T6412 |
themeOf |
the tumor tissues of the CCR5−/− mice,the tumor tissues of the CCR5−/− mice |
R4909 |
T7215 |
T7228 |
themeOf |
of IL-1Ra,The expression of IL-1Ra |
R4910 |
T7216 |
T7226 |
themeOf |
of IL-1Ra,the expression of IL-1Ra in tumor and spleen tissues was analyzed by immunofluorescence and western |
R4911 |
T7223 |
T7227 |
themeOf |
of IL-1Ra,Upregulation of IL-1Ra in the Tumor and Spleen of CCR5−/− Mice |
R4912 |
T7228 |
T7225 |
themeOf |
The expression of IL-1Ra,The expression of IL-1Ra was upregulated in tumor and spleen tissues of the CCR5−/− |
R5871 |
T8618 |
T8670 |
themeOf |
"− mice in immunity-related organ,","− mice in immunity-related organ," |